SPCB vs. GLMD
SPCB (SuperCom Ltd.) and GLMD (Galmed Pharmaceuticals Ltd.) are both stocks. SPCB operates in Security & Protection Services (Industrials), while GLMD operates in Biotechnology (Healthcare). Over the past 10 years, SPCB returned -33.87%/yr vs -51.09%/yr for GLMD. Their 0.10 correlation means their historical movements had little consistent relationship.
Performance
SPCB vs. GLMD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SPCB achieves a 19.89% return, which is significantly higher than GLMD's -22.05% return. Over the past 10 years, SPCB has outperformed GLMD with an annualized return of -33.87%, while GLMD has yielded a comparatively lower -51.09% annualized return.
SPCB
- 1D
- 1.31%
- 1M
- -4.32%
- 6M
- 15.67%
- YTD
- 19.89%
- 1Y
- 25.00%
- 3Y*
- -13.87%
- 5Y*
- -46.61%
- 10Y*
- -33.87%
- ALL TIME*
- -28.02%
GLMD
- 1D
- -5.80%
- 1M
- 2.56%
- 6M
- -12.08%
- YTD
- -22.05%
- 1Y
- -62.26%
- 3Y*
- -64.06%
- 5Y*
- -74.01%
- 10Y*
- -51.09%
- ALL TIME*
- -49.89%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $233.84K | $502.38K | $414.00K | |
SPCB SuperCom Ltd. | $678.39K | $885.76K | $940.19K |
SPCB vs. GLMD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SPCB SuperCom Ltd. | 19.89% | 87.76% | -37.60% | -78.30% | -67.93% | -46.12% | 66.13% | -55.07% | -64.71% | 15.34% |
GLMD Galmed Pharmaceuticals Ltd. | -22.05% | -76.47% | -41.58% | -93.93% | -72.53% | -41.48% | -46.19% | -15.37% | -25.36% | 160.68% |
Correlation
The correlation between SPCB and GLMD is 0.15, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.15 |
Correlation (3Y) Balances recent behavior with more history. | 0.08 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.08 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.09 |
Correlation (All Time) Calculated using the full available price history since Mar 13, 2014 | 0.10 |
Fundamentals
SPCB:
$48.26M
GLMD:
$4.83M
SPCB:
$0.89
GLMD:
-$1.71
SPCB:
1.24
GLMD:
0.24
SPCB:
$27.90M
GLMD:
$0.00
SPCB:
$15.39M
GLMD:
$0.00
SPCB:
$4.32M
GLMD:
-$8.49M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SPCB vs. GLMD — Risk / Return Rank
SPCB
GLMD
SPCB vs. GLMD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SuperCom Ltd. (SPCB) and Galmed Pharmaceuticals Ltd. (GLMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SPCB | GLMD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.03 | ||
| Sortino ratioReturn per unit of downside risk | +1.92 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 0.90 | +0.22 |
| Calmar ratioReturn relative to maximum drawdown | 0.55 | -0.88 | +1.43 |
| Martin ratioReturn relative to average drawdown | 0.96 | -1.25 | +2.21 |
Loading charts...
Drawdowns
SPCB vs. GLMD - Drawdown Comparison
The maximum SPCB drawdown since its inception was -99.98%, roughly equal to the maximum GLMD drawdown of -99.99%. Use the drawdown chart below to compare losses from any high point for SPCB and GLMD.
Loading charts...
Drawdown Indicators
| SPCB | GLMD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.98% | -99.99% | +0.01% |
Max Drawdown (1Y)Largest decline over 1 year | -45.37% | -71.21% | +25.84% |
Max Drawdown (3Y)Largest decline over 3 years | -84.72% | -96.89% | +12.17% |
Max Drawdown (5Y)Largest decline over 5 years | -98.92% | -99.92% | +1.00% |
Max Drawdown (10Y)Largest decline over 10 years | -99.69% | -99.99% | +0.30% |
Current DrawdownCurrent decline from peak | -99.91% | -99.98% | +0.07% |
Average DrawdownAverage peak-to-trough decline | -91.54% | -76.28% | -15.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.19% | 49.76% | -23.57% |
Volatility
SPCB vs. GLMD - Volatility Comparison
SuperCom Ltd. (SPCB) and Galmed Pharmaceuticals Ltd. (GLMD) have volatilities of 21.21% and 20.78%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SPCB | GLMD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.21% | 20.78% | +0.43% |
Volatility (6M)Calculated over the trailing 6-month period | 48.08% | 76.24% | -28.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 71.47% | 92.10% | -20.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 122.77% | 166.87% | -44.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 114.95% | 138.38% | -23.43% |
Dividends
SPCB vs. GLMD - Dividend Comparison
Neither SPCB nor GLMD has paid dividends to shareholders.
Financials
SPCB vs. GLMD - Financials Comparison
This section allows you to compare key financial metrics between SuperCom Ltd. and Galmed Pharmaceuticals Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SPCB and GLMD have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SPCB has higher volatility (21.21%) compared to GLMD (20.78%). In terms of maximum drawdown, SPCB dropped -99.98% vs GLMD's -99.99%.
SPCB currently has the higher Sharpe Ratio (0.35 vs -0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SPCB and GLMD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer